ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,151,362 | +428.0% | 226,653 | +498.0% | 0.02% | +500.0% |
| Q2 2023 | $1,165,015 | -52.7% | 37,899 | -44.6% | 0.00% | -57.1% |
| Q1 2023 | $2,464,884 | -2.9% | 68,412 | +6.5% | 0.01% | -12.5% |
| Q4 2022 | $2,538,132 | +25.1% | 64,224 | +27.2% | 0.01% | +33.3% |
| Q3 2022 | $2,029,000 | +88.4% | 50,487 | +97.0% | 0.01% | +100.0% |
| Q2 2022 | $1,077,000 | +48.6% | 25,623 | +37.8% | 0.00% | +50.0% |
| Q1 2022 | $725,000 | +1088.5% | 18,600 | +1228.6% | 0.00% | – |
| Q1 2021 | $61,000 | -97.0% | 1,400 | -96.6% | 0.00% | -100.0% |
| Q4 2020 | $2,042,000 | – | 40,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |